| LLYELI LILLY & Co | 9,223,432 | $8.48B |
| AZNASTRAZENECA PLC | 18,213,708 | $3.59B |
| AMGNAMGEN INC | 8,874,129 | $3.12B |
| BIIBBIOGEN INC. | 14,757,607 | $2.71B |
| BMYBRISTOL MYERS SQUIBB CO | 24,985,149 | $1.52B |
| ONCBeOne Medicines Ltd. | 4,975,181 | $1.48B |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 25,204,538 | $1.39B |
| NVSNovartis AG | 7,567,354 | $1.16B |
| ELANElanco Animal Health Inc | 45,840,956 | $1.10B |
| BMRNBIOMARIN PHARMACEUTICAL INC | 14,194,005 | $801.8M |
| ZBHZimmer Biomet Holdings Inc. | 3,907,150 | $353.3M |
| BNTXBioNTech SE | 3,793,711 | $337.2M |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 3,417,509 | $297.2M |
| PMPhilip Morris International Inc | 864,400 | $142.9M |
| XNCRXencor Inc | 10,338,022 | $124.7M |
| IMCRImmunocore Holdings plc | 3,693,241 | $111.4M |
| IMNMImmunome Inc. | 4,788,231 | $104.7M |
| ALKSAlkermes plc. | 2,539,990 | $89.8M |
| ABTABBOTT LABORATORIES | 762,220 | $78.3M |
| NBIXNEUROCRINE BIOSCIENCES INC | 496,340 | $65.4M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 186,521 | $50.5M |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 266,890 | $46.0M |
| BBIOBridgeBio Pharma, Inc. | 569,180 | $42.3M |
| WVEWave Life Sciences Ltd. | 4,832,952 | $35.0M |
| RGENREPLIGEN CORP | 235,068 | $27.7M |
| SEPNSepterna, Inc. | 1,048,834 | $25.2M |
| PVLAPALVELLA THERAPEUTICS, INC. | 195,030 | $24.3M |
| ALLOAllogene Therapeutics, Inc. | 8,379,840 | $20.4M |
| NKTRNEKTAR THERAPEUTICS | 279,150 | $20.1M |
| IQVIQVIA Holdings Inc. | 62,332 | $10.6M |
| FOLDAMICUS THERAPEUTICS, INC. | 585,400 | $8.5M |
| SNYSanofi | 97,168 | $4.7M |
| LENZLENZ Therapeutics, Inc. | 472,200 | $4.3M |
| MRKMerck & Co., Inc. | 35,900 | $4.3M |
| GMEDGlobus Medical Inc. | 29,325 | $2.5M |
| ARRYARRAY BIOPHARMA INC | 313,300 | $2.3M |
| ZNTLZentalis Pharmaceuticals, Inc. | 957,420 | $2.2M |